We serve Chemical Name:2-hydroxycyclohexanone dimer CAS:60308-50-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-hydroxycyclohexanone dimer
CAS.NO:60308-50-1
Synonyms:1,8-dihydroxy-9,14-dioxa-tricyclo(8.4.0.08,13)tetradecane;ADIPOIN DIMER
Molecular Formula:C12H20O4
Molecular Weight:228.28500
HS Code:2932999099
Physical and Chemical Properties:
Melting point:100-107ºC(lit.)
Boiling point:83-86ºC13 mm Hg(lit.)
Density:N/A
Index of Refraction:
PSA:58.92000
Exact Mass:228.13600
LogP:1.29560
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1325 4.1/PG 3
Packing Group:
Contact us for information like 1,8-dihydroxy-9,14-dioxa-tricyclo(8.4.0.08,13)tetradecane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ADIPOIN DIMER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,8-dihydroxy-9,14-dioxa-tricyclo(8.4.0.08,13)tetradecane Use and application,1,8-dihydroxy-9,14-dioxa-tricyclo(8.4.0.08,13)tetradecane technical grade,usp/ep/jp grade.
Related News: This is how an API becomes a medicine. 2-hydroxycyclohexanone dimer manufacturer However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-hydroxycyclohexanone dimer supplier The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 2-hydroxycyclohexanone dimer vendor However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-hydroxycyclohexanone dimer factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 2-hydroxycyclohexanone dimer vendor However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-hydroxycyclohexanone dimer factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
